| NCT ID | NCT06970977 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The European Forum for Research and Education in Allergy and Airway Diseases |
| Condition | Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-09-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The 'CRS validation project' consists of a joint effort of 32 medical centers in Europe, the USA, and South Africa to carry out the validation of 2 novel questionnaires designated to measure self-perceived severity and control of Chronic Rhinosinusitis (with or without nasal polyps). This study will validate translated versions of the same set of questionnaires simultaneously in the centers involved after recruiting a total of 1000 patients, while data collection, statistical analysis, and creation of the study report will be carried out by the statistical department of the University of Leuven. Patients will be recruited from the regular ENT practice of their hospital to minimize the complexity of the study.
Eligibility Criteria
Inclusion Criteria: * Patient capable of giving informed consent * Diagnosis of chronic rhinosinusitis with or without nasal polyposis according to the EPOS guidelines * No recent sinus surgery (within the last three months) Exclusion Criteria: * Not capable of giving informed consent * No CRS * Recent sinus surgery (within the last three months)
Frequently Asked Questions
Who can join the NCT06970977 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06970977 currently recruiting?
Yes, NCT06970977 is actively recruiting participants. Visit ClinicalTrials.gov or contact The European Forum for Research and Education in Allergy and Airway Diseases to inquire about joining.
Where is the NCT06970977 trial being conducted?
This trial is being conducted at Santa Monica, United States, Chicago, United States, Boston, United States, Philadelphia, United States and 11 additional locations.
Who is sponsoring the NCT06970977 clinical trial?
NCT06970977 is sponsored by The European Forum for Research and Education in Allergy and Airway Diseases. The trial plans to enroll 1,000 participants.